- Latest available (Revised)
- Original (As made)
(This note is not part of the Regulations)
These Regulations further amend the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 1973 (“the principal Regulations”) as follows—
(a)regulation 2(a) increases the fees for registration of premises at which a retail pharmacy business is, or is to be, carried on from £474 to £492 (where the premises are in Great Britain) and from £93 to £97 (where the premises are in Northern Ireland);
(b)regulation 2(b) increases subsequent annual fees (retention fees) from £150 to £156 (where the premises are in Great Britain) and from £130 to £135 (where the premises are in Northern Ireland);
(c)regulation 2(c) increases the penalty for failure to pay retention fees (payable in circumstances specified in section 76(2) of the Medicines Act 1968) from £474 to £492 (where premises are in Great Britain) and from £270 to £281 (where the premises are in Northern Ireland).
These Regulations also revoke the Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2005, which increased the fees in the principal Regulations, the effect of which is spent.
A full Regulatory Impact Assessment of the effect that this instrument will have on the costs of business is available from the Department of Health, Pharmacy and Prescription Branch, Room 520, Eileen House, 80-90 Newington Causeway, London SE1 6EE. Copies have been placed in the libraries of both Houses of Parliament.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Click 'View More' or select 'More Resources' tab for additional information including: